These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16427778)

  • 1. Recent developments in the use of chemotherapy in brain tumours.
    van den Bent MJ; Hegi ME; Stupp R
    Eur J Cancer; 2006 Mar; 42(5):582-8. PubMed ID: 16427778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
    Schiff D
    Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
    Kouwenhoven MC; Kros JM; French PJ; Biemond-ter Stege EM; Graveland WJ; Taphoorn MJ; Brandes AA; van den Bent MJ
    Eur J Cancer; 2006 Oct; 42(15):2499-503. PubMed ID: 16914310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy for brain tumors in adult patients].
    Weller M
    Nervenarzt; 2008 Feb; 79(2):231-41. PubMed ID: 18253773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma.
    Kocher M; Kunze S; Eich HT; Semrau R; Müller RP
    Strahlenther Onkol; 2005 Mar; 181(3):157-63. PubMed ID: 15756519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targeted therapies and chemotherapy in malignant gliomas.
    Brandsma D; van den Bent MJ
    Curr Opin Oncol; 2007 Nov; 19(6):598-605. PubMed ID: 17906459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
    Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
    Siker ML; Chakravarti A; Mehta MP
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuro-oncology: the growing role of chemotherapy in glioma.
    Carpentier AF
    Lancet Neurol; 2005 Jan; 4(1):4-5. PubMed ID: 15620846
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.
    Brandes AA; Tosoni A; Cavallo G; Reni M; Franceschi E; Bonaldi L; Bertorelle R; Gardiman M; Ghimenton C; Iuzzolino P; Pession A; Blatt V; Ermani M;
    J Clin Oncol; 2006 Oct; 24(29):4746-53. PubMed ID: 16954518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
    Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
    Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of Oligodendrogliomas.
    Drappatz J; Lieberman F
    Prog Neurol Surg; 2018; 31():152-161. PubMed ID: 29393183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of adjuvant chemotherapy in high-grade gliomas.
    DeAngelis LM
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide: a milestone in neuro-oncology and beyond?
    Mutter N; Stupp R
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1187-204. PubMed ID: 16925485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
    Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A
    Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.